Genzyme

LEMTRADA

Manufacturer:

Genzyme

Lemtrada HCPCS:

J0202

HCPCS Code Descriptor:

Injection, alemtuzumab, 1 mg

Category:

J Code

Lemtrada NDCs:

58468-0200-01

Primary Type:

Neurology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Lemtrada:

LEMTRADA is a Neurology drug manufactured by Genzyme and administered via the Intravenous route of administration. The J Code: J0202 is aligned to the drug LEMTRADA.

ACCESS PRICING AND MORE BY REGISTERING

J0202 Added Date:

January 1, 2016

J0202 Effective Date:

January 1, 2016

J0202 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Lemtrada billing and coding information.
Lemtrada patient assistance information can be found through MS LifeLines at the URL: https://www.msonetoone.com/
LEMTRADA prescribing information can be found at the link below:
Information regarding LEMTRADA’s side effects can be found at MedlinePlus